Loading...

Terns Pharmaceuticals, Inc.

TERN•NASDAQ
Healthcare
Biotechnology
$52.89
$0.06(0.11%)
U.S. Market opens in 49h 27m

Terns Pharmaceuticals, Inc. (TERN) Stock Overview

Explore Terns Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap4.8B
P/E Ratio-51.21
EPS (TTM)$-1.03
ROE-0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$43.87
3 Months$56.71
1 Year Target$25.83

TERN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Terns Pharmaceuticals, Inc. (TERN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.06, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $25.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -51.21 and a market capitalization of 4.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.11%
5-Day Change
0.32%
1-Month Change
5.78%
3-Month Change
54.06%
6-Month Change
580.69%
Year-to-Date (YTD) Change
30.92%
1-Year Change
1634.10%
3-Year Change
299.77%
5-Year Change
150.43%
All-Time (Max) Change
187.60%

Contact Information

https://www.ternspharma.com
650 525 5535
1065 East Hillsdale Boulevard, Foster City, CA, 94404

Company Facts

590 Employees
IPO DateFeb 5, 2021
CountryUS
Actively Trading

Frequently Asked Questions